Skip to search formSkip to main contentSkip to account menu

metreleptin

Known as: Metreleptinum, Métréleptine, Metreleptina 
National Institutes of Health

Related topics

Related topics

5 relations

Narrower (1)

Myalept
analogs & derivativesmetreleptin 5 MG/ML Injectable Solution [Myalept]recombinant methionyl human leptin

Broader (1)

leptin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
First metreleptin treatment for generalized lipodystrophy in Turkey
To the Editor: We report the first patient with generalized lipodystrophy (GL) treated with metreleptin in Turkey. GL is a rare… 
2017
2017
Facial soft tissue volume decreases during metreleptin treatment in patients with partial and generalized lipodystrophy
PurposeLipodystrophy (LD) patients suffer from loss or maldistribution of subcutaneous adipose tissue accompanied by… 
2016
2016
Serum concentrations of fibroblast growth factor 21 are elevated in patients with congenital or acquired lipodystrophy.
2014
2014
Recombinant Human Leptin Does Not Alter Gut Hormone Levels after Gastric Bypass but May Attenuate Sweet Cravings
Bariatric surgery improves glucose homeostasis and alters gut hormones partly independent of weight loss. Leptin plays a role in… 
2013
2013
Metreleptin improves blood glucose in patients with insulin receptor mutations.
CONTEXT Rabson-Mendenhall syndrome (RMS) is caused by mutations of the insulin receptor and results in extreme insulin resistance… 
2013
2013
Gender Dimorphism and Lack of Day/Night Variation or Effects of Energy Deprivation on Undercarboxylated Osteocalcin Levels in Humans
Undercarboxylated osteocalcin (ucOC) is a bone marker with potent metabolic effects. Leptin regulates Esp gene expression and… 
2011
2011
Leptin administered in physiological or pharmacological doses does not regulate circulating angiogenesis factors in humans
Aim/hypothesisLeptin has been shown to regulate angiogenesis in animal and in vitro studies by upregulating the production of… 
Review
2010
Review
2010
[Recent progress and novel perspectives on obesity pharmacotherapy].
Obesity prevalence has risen dramatically over the past decades, which poses a great number of patients at risk of metabolic and… 
2010
2010
W(h)ither metreleptin for lipodystrophy and the metabolic syndrome?
2010
2010
Amylin's $1 billion heavyweight deal
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)